Edward D. Freedman Net Worth

What's Edward Freedman's mailing address?

Edward's mailing address filed with the SEC is C/O PANDION THERAPEUTICS, INC., 134 COOLIDGE AVENUE, WATERTOWN, MA, 02472.

Insiders trading at Pandion Therapeutics

Over the last 4 years, insiders at Pandion Therapeutics have traded over $0 worth of Pandion Therapeutics stock and bought 1,743,632 units worth $30,815,954 . The most active insiders traders include Plc Gsk, Capital Management, L.P.Kol... a Daniel J. Becker. On average, Pandion Therapeutics executives and independent directors trade stock every 11 days with the average trade being worth of $9,518,646. The most recent stock trade was executed by Daniel J. Becker on 19 November 2020, trading 197,716 units of PAND stock currently worth $2,989,466.

What does Pandion Therapeutics do?

Pandion Therapeutics executives and stock owners

Pandion Therapeutics executives and other stock owners filed with the SEC include:

• Capital Management, L.P.Kol...,
  
• Nancy Stagliano,
  Director
• Vikas Goyal,
  See Remarks
• Joanne L. Viney,
  See Remarks
• Partners Gp Viii, L.L.C.Pol...,
  
• Rizzuto Carlo,
  Director
• Jill Carroll,
  Director
• Katina Dorton,
  Director
• Donald Frail,
  Director
• Christopher Fuglesang,
  Director
• Gregg Beloff,
  See Remarks
• Alan L Crane,
  Director
• Mitchell Mutz,
  Director
• Eric D Larson,
  Vice President, Finance
• Daniel J. Becker,
  Director
• Rahul Kakkar,
  Chief Executive Officer
• Plc Gsk,
  Director
• John Sundy,
  Chief Medical Officer
• Edward D. Freedman,
  Chief Operating Officer